Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
暂无分享,去创建一个
T. Imamura | T. Fujino | I. Komuro | M. Ono | S. Kyo | K. Kinugawa | O. Kinoshita | M. Endo | M. Hatano | H. Maki | K. Nawata | Y. Kagami | Toshiro Inaba | H. Muraoka | Takahide Murasawa | T. Inaba | Hironori Muraoka
[1] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official pediatric heart transplantation report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] D. Renlund,et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] R. Starling,et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] L. Merello,et al. Prevalence of cardiac allograft vasculopathy assessed with coronary angiography versus coronary vascular ultrasound and virtual histology. , 2011, Transplantation proceedings.
[5] I. Komuro,et al. Cardiac allograft vasculopathy progression associated with intraplaque neovascularization. , 2013, Journal of the American College of Cardiology.
[6] G. Steinbeck,et al. Heart failure/transplant: abstractSimvastatin initiated early after heart transplantation: 8-year prospective experience☆ , 2003 .
[7] Amir Lerman,et al. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. , 2013, European heart journal.
[8] N. Smedira,et al. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] Akiko Maehara,et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. , 2012, Journal of the American College of Cardiology.
[10] G. Ripandelli,et al. Optical coherence tomography. , 1998, Seminars in ophthalmology.
[11] C. Toma,et al. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study). , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] M. Fishbein,et al. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] B. Rangan,et al. Low molecular weight dextran provides similar optical coherence tomography coronary imaging compared to radiographic contrast media , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[14] B. McManus,et al. Allograft Vasculopathy Versus Atherosclerosis , 2006, Circulation research.
[15] T. Akasaka,et al. Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[16] P. Serruys,et al. Studies Reproducibility of Intravascular Ultrasound iMAP for Radiofrequency Data Analysis : Implications for Design of Longitudinal Studies , 2014 .
[17] T. Cooper,et al. RETURN OF NEURAL RESPONSES AFTER AUTOTRANSPLANTATION OF THE HEART. , 1964, The American journal of physiology.
[18] Josef Stehlik,et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[19] E. Tuzcu,et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. , 2003, The New England journal of medicine.
[20] L. Mestroni,et al. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. , 2004, Circulation.
[21] Eiji Toyota,et al. Assessment of coronary intima--media thickness by optical coherence tomography: comparison with intravascular ultrasound. , 2005, Circulation journal : official journal of the Japanese Circulation Society.